“Based upon the information We've noticed in the TRIDENT-one demo, repotrectinib has the prospective to be a fresh common of treatment selection for individuals with regionally Sophisticated or metastatic ROS1 fusion-beneficial lung cancer.”Disclaimer: The data furnished on this webpage will not be a substitute for Expert medical tips, analysis… Read More